The short version
Only one company currently supplies this market — there is no backup if it stumbles.
Market view
dexbrompheniramine maleate · Concentrate
1 marketed package NDCs · 1 active manufacturer
Most dispensed: 2 mg · Tablet · #60 tablets/bottle, plastic
What changed in the last 90 days
Every detected change for dexbrompheniramine maleate, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.
- Ala-Hist IrJul 22, 2026Price upNADAC $0.65946 → $0.66057 per unit (+0.17%)
Common questions
- Is Dexbrompheniramine maleate in shortage right now?
- No. FDA does not currently list Dexbrompheniramine maleate in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
- Who makes Dexbrompheniramine maleate?
- 3 companies have marketed Dexbrompheniramine maleate in the last 30 days, according to the FDA NDC Directory. That is a thin market — if one stops making it, supply is at risk quickly. Every manufacturer and package is listed on this page.
- What does Dexbrompheniramine maleate cost?
- The typical pharmacy pays about $0.6606 per unit, based on the most recent CMS NADAC survey of actual acquisition costs. That is what the pharmacy pays for the drug itself — not the cash price, and not what an insurer is billed.
All marketed products
Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.